Rxivist logo

Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS CoV 2

By Alasdair P. MacGowan, Fergus Hamilton, Mark Bayliss, Liam Read, Marie Attwood, Alan Noel, Sally Grier, Anna Morley, David Arnold, Nick maskell

Posted 23 Jun 2020
medRxiv DOI: 10.1101/2020.06.23.20137992

Hydroxychloroquine(HCQ) has been widely used to treat SARS-CoV-2 infection however HCQ pharmacokinetics in this condition have not been studied in non-critical care patient groups. Here we report the serum concentrations of HCQ in a small cohort of patients treated with HCQ as part of the RECOVERY trial.

Download data

  • Downloaded 3,041 times
  • Download rankings, all-time:
    • Site-wide: 5,104
    • In pharmacology and therapeutics: 16
  • Year to date:
    • Site-wide: 10,121
  • Since beginning of last month:
    • Site-wide: 15,347

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

News